According to the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, Chronic Insomnia is the condition when symptoms of insomnia are present for at least three nights per week lasting for at least three months. It is worth mentioning that it must not be linked to other sleep, medical, or mental disorders, as it is often associated with a wide range of adverse conditions, including mood disturbances, difficulties with concentration, and memory. Insomnia is defined as the subjective perception of difficulty with sleep initiation, duration, consolidation, or quality that occurs despite adequate opportunity for sleep, and that results in some form of daytime impairment.
Consistent risk factors for chronic insomnia include increasing age, female sex, comorbid (medical, psychiatric, sleep, and substance use) disorders, shift work, and possibly unemployment and lower socioeconomic status. Women and older adults are at a higher risk for insomnia.
Get FREE sample copy at:
The Chronic Insomnia market report also covers emerging drugs, current treatment practices, Chronic Insomnia market share of the individual therapies, current and forecasted Chronic Insomnia Market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Chronic Insomnia treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Chronic Insomnia Market Key Facts
According to the literature review, in the general population, about one of three adults’ reports at least occasional symptoms of insomnia, while chronic insomnia affects about 1 in 10 adults. (David et al.)
As per the Ancoli et al., the actual prevalence of insomnia varies according to the stringency of the definition used. Insomnia symptoms occur in approximately 33–50% of the adult population among which insomnia symptoms with distress or impairment are observed in 10–15% cases, whereas specific insomnia disorders occur in 5–10% cases.
Patients with comorbid medical and psychiatric conditions are at particularly increased risk, with psychiatric and chronic pain disorders having insomnia rates as high as 50–75 %. (Taylor et al.)
Key Benefits of Chronic Insomnia Market Report
Chronic Insomnia market report provides an in-depth analysis of Chronic Insomnia Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
The Chronic Insomnia market report will help in developing business strategies by understanding the Chronic Insomnia Market trends & developments, key players and future market competition that will shape and drive the Chronic Insomnia market in the upcoming years.
The Chronic Insomnia market report covers Chronic Insomnia current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
The report provides a detailed assessment of the Chronic Insomnia market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
Chronic Insomnia Market
Chronic Insomnia market size is expected to increase owing to the higher prevalence of Chronic Insomnia during the forecast period.
The Chronic Insomnia market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Chronic Insomnia market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Chronic Insomnia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Chronic Insomnia Epidemiology
The Chronic Insomnia epidemiology section covers insights about historical and current Chronic Insomnia patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Chronic Insomnia Drugs Uptake and Key Market Players
The Chronic Insomnia Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Chronic Insomnia market or expected to get launched in the market during the study period. The analysis covers Chronic Insomnia market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The goal of treatment for chronic insomnia is to improve sleep and alleviate distress or dysfunction caused by the disorder. Chronic Insomnia can be managed with psychological therapy, pharmacologic therapy, or a combination of both.
Some of the Key Chronic Insomnia Companies Involved in Therapeutics Development Include:
And many others
Chronic Insomnia Therapies Covered in the Report Include:
And many more.
Table of Content
1. Key Insights
2. Executive Summary
3. Chronic Insomnia Competitive Intelligence Analysis
4. Chronic Insomnia Market Overview at a Glance
5. Chronic Insomnia Disease Background and Overview
6. Chronic Insomnia Patient Journey
7. Chronic Insomnia Epidemiology and Patient Population
8. Chronic Insomnia Treatment Algorithm, Current Treatment, and Medical Practices
9. Chronic Insomnia Unmet Needs
10. Key Endpoints of Chronic Insomnia Treatment
11. Chronic Insomnia Marketed Products
12. Chronic Insomnia Emerging Therapies
13. Chronic Insomnia Seven Major Market Analysis
14. Attribute Analysis
15. Chronic Insomnia Market Outlook (7 major markets)
16. Chronic Insomnia Access and Reimbursement Overview
17. KOL Views on the Chronic Insomnia Market.
18. Chronic Insomnia Market Drivers
19. Chronic Insomnia Market Barriers
21. DelveInsight Capabilities
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Address:304 S. Jones Blvd. 2432
City: Las Vegas
Country: United States